o 11: diagnosis and management of neuromyelitis optica

Authors

mohammad ali sahraian neuroscience institute, tehran university of medical sciences, tehran, iran

abstract

typical nmo is characterized by simultaneous or sequential acute transverse myelitis and optic neuritis. spinal cord lesions extending over 3 or more vertebral segments and normal brain imaging are the typical mri findings in nmo. in typical cases with positive nmo antibody the diagnosis is easy but in seronegative and atypical cases with different clinical manifestations and mri features the diagnosis will be challenging. brain stem syndromes such as ataxia, intractable vomiting and cranial nerve palsies are less common initial manifestations of nmo.  shorter spinal cord lesions in mri can be found very early during relapse or in residual atrophic stages. some of the lesions may appear hypointense on corresponding t1-weighted images which reflects sever inflammation with necrosis. t1-weighted hypointensities may help in differentiating nmo lesions from ms in spinal cord. brain mri is initially normal in most patients with nmo but serial imaging may depict lesions in up to 85% of the patients at later stages. brain lesions are usually nonspecific but may fulfill the barkhof criteria for dissemination in space. acute, large, edematous callosal lesions with a heterogeneous intensity occasionally develop in patients with nmo (marbled pattern). in contrast, in ms, callosal lesions are small, non-edematous, and the intensity was homogeneous in the acute phase and located at the lower margin of the corpus callosum. multiple patchy enhancements with blurred margins (cloudlike enhancement) have been reported to be typical for nmo. pencil-like ependymal enhancement is another type of enhancement around the anterior horns of lateral ventricles. extensive hemispheric lesions, periependymal lesions surrounding the aqueduct, the third and fourth ventricles and brain stem lesions should raise the diagnosis of nmo. actually nmo should be considered in any atypical lesion for ms in appropriate clinical settings. other auto anti bodies such as anti mog  have extended the spectrum of this entity and should be evaluated in special cases who are seronegative for anti-aquaporin 4. treatment of nmo consists of acute relapse management with steroids and/or plasma exchange and prevention of exacerbations with cytoxic agents or rituximab.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

O 11: Diagnosis and Management of Neuromyelitis Optica

Typical NMO is characterized by simultaneous or sequential acute transverse myelitis and optic neuritis. Spinal cord lesions extending over 3 or more vertebral segments and normal brain imaging are the typical MRI findings in NMO. In typical cases with positive NMO antibody the diagnosis is easy but in seronegative and atypical cases with different clinical manifestations and MRI features the d...

full text

EFNS guidelines on diagnosis and management of neuromyelitis optica.

BACKGROUND AND PURPOSE Neuromyelitis optica (NMO) or Devic's disease is a rare inflammatory and demyelinating autoimmune disorder of the central nervous system (CNS) characterized by recurrent attacks of optic neuritis (ON) and longitudinally extensive transverse myelitis (LETM), which is distinct from multiple sclerosis (MS). The guidelines are designed to provide guidance for best clinical pr...

full text

[Diagnosis and treatment of neuromyelitis optica].

Neuromyelitis optica (NMO) is an inflammatory demyelinating disease characterized by antibodies against aquaporin-4 in up to 80% of the cases and even less in the NMO spectrum disorders, which may be difficult to distinguish from early multiple sclerosis. While immunosuppressive therapy should be introduced in definite NMO, treatment strategies of NMO spectrum disorders are less clearly defined...

full text

Neuromyelitis Optica Spectrum Disorders: Diagnosis and Treatment

The last decade has witnessed rapid developments in the clinical understanding and scienti fi c foundati on of neuromyeliti s opti ca (NMO). The landmark events were the late 19th century report by Devic and Gault describing the associati on of severe acute transverse myeliti s and opti c neuriti s and the late 20th century discovery that the syndrome was associated with a specifi c autoanti bo...

full text

Neuromyelitis Optica

An 11-year-old girl developed sudden visual loss in her left eye, preceding subacute myelitis by 9 months. Multifocal lesions in the central nervous system were demonstrated by magnetic resonance imaging. Although unilateral blindness is unusual, the clinical findings predominantly involving the optic nerve and spinal cord were consistent with the diagnosis of neuromyelitis optica (NMO). This c...

full text

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate

BACKGROUND To review our experience using methotrexate as a single long-term immunosuppressant (IS) therapy in neuromyelitis optica/neuromyelitis optica spectrum disorders (NMO/NMOSD). METHODS We performed a retrospective chart review of all patients with a diagnosis of NMO/NMOSD, supported by a positive NMO-IgG testing, who were treated with methotrexate. A paired sample 2 tailed t test was ...

full text

My Resources

Save resource for easier access later


Journal title:
مجله علوم اعصاب شفای خاتم

جلد ۵، شماره ۲، صفحات ۱۱-۱۱

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023